> Blulux Laboratories Pvt. Ltd.

CAS # 51 - 43 - 4 L - ADRENALINE

Blulux Laboratories Pvt. Ltd
79/66-B, I.H.I.Complex, H/W Chowk Industrial Area, N.I.T. Faridabad - 1, Haryana (India)
Tel. : + 91 129 4021360, 4190300 
Fax : + 91 129 4190333
E-mail: bluluxlab@gmail.com  Website : www.blulux.com


 

 

Section 1 - Chemical Product and Company Identification

 

MSDS Name: L - Adrenaline
Synonyms: l-3,4-Dihydroxy-Alpha-(Methylaminomethyl)Benzyl Alcohol; Adrenaline, L(-)-Epinephrine
 

Section 2 - Composition, Information on Ingredients


 

CAS#

Chemical Name

Percent

EINECS/ELINCS

51-43-4

L - Adrenaline

99

200-098-7

 

Section 3 - Hazards Identification

EMERGENCY OVERVIEW

Appearance: white to light beige crystalline powder.
Warning! Harmful if swallowed, inhaled, or absorbed through the skin. Causes eye, skin, and respiratory tract irritation. May cause central nervous system effects. May cause central nervous system depression. Light sensitive. Air sensitive. May cause cardiac disturbances. The toxicological properties of this material have not been fully investigated.
Target Organs: Central nervous system, respiratory system, cardiovascular system, eyes, skin.


Potential Health Effects
Eye: Causes eye irritation. At high concentrations may cause lacrimation (tearing) and irritation. May cause chemical conjunctivitis.
Skin: Causes skin irritation. May be absorbed through the skin in harmful amounts.
Ingestion: May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause cardiac disturbances. The toxicological properties of this substance have not been fully investigated. May cause central nervous system depression. May be harmful if swallowed.
Inhalation: May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. May be harmful if inhaled. May cause cardiac damage. Can produce delayed pulmonary edema. Inhalation at high concentrations may cause CNS depression and asphixiation.
Chronic: Effects may be delayed.

 

Section 4 - First Aid Measures


Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion: Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician: Treat symptomatically and supportively.

 

Section 5 - Fire Fighting Measures

General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Containers may explode in the heat of a fire. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media: In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam. Use water spray to cool fire-exposed containers.
Flash Point: Not available.
Autoignition Temperature: Not available.
Explosion Limits, Lower: Not available.
Upper: Not available.
NFPA Rating: (estimated) Health: 2; Flammability: 0; Instability: 1

Section 6 - Accidental Release Measures


General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks: Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up, then place into a suitable container for disposal. Provide ventilation. Place under an inert atmosphere.

Section 7 - Handling and Storage


Handling: Wash thoroughly after handling. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Store protected from light. Handle under an inert atmosphere. Store protected from air. Wash clothing before reuse.
Storage: Keep refrigerated. (Store below 4°C/39°F.) Store in a tightly closed container. Poison room locked/refrigerator. Do not expose to air. Store protected from light. Store under an inert atmosphere.

Section 8 - Exposure Controls, Personal Protection


Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits.
Exposure Limits

Chemical Name

ACGIH

NIOSH

OSHA - Final PELs

L-Adrenaline

none listed

none listed

none listed


OSHA Vacated PELs: L(-)-Epinephrine: No OSHA Vacated PELs are listed for this chemical.
Personal Protective Equipment
Eyes: Wear safety glasses and chemical goggles if splashing is possible.
Skin: Wear appropriate protective gloves and clothing to prevent skin exposure.
Clothing: Wear appropriate protective clothing to minimize contact with skin.
Respirators: Wear a NIOSH/MSHA or European Standard EN 149 approved full-facepiece airline respirator in the positive pressure mode with emergency escape provisions.

Section 9 - Physical and Chemical Properties


Physical State: Crystalline powder
Appearance: white to light beige
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Vapor Density: Not available.
Evaporation Rate: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point:208-211 deg C
Decomposition Temperature:> 212 deg C
Solubility: slightly soluble
Specific Gravity/Density: Not available.
Molecular Formula:C9H13NO3
Molecular Weight:183.21

Section 10 - Stability and Reactivity


Chemical Stability: Stable under normal temperatures and pressures.
Conditions to Avoid: Incompatible materials, light, exposure to air, excess heat.
Incompatibilities with Other Materials: Acid chlorides, acids, oxidizing agents.
Hazardous Decomposition Products: Nitrogen oxides, carbon monoxide, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported.

Section 11 - Toxicological Information


RTECS#:      
CAS# 51-43-4: DO2625000
LD50/LC50:
CAS# 51-43-4:
     Skin, rat: LD50 = 62 mg/kg;<BR.

Carcinogenicity:
CAS# 51-43-4: Not listed by ACGIH, IARC, NTP, or CA Prop 65.

Epidemiology: No information found.
Teratogenicity: No information found.
Reproductive Effects: Adverse reproductive effects have occurred in experimental animals.
Mutagenicity: Mutagenic effects have occurred in experimental animals.
Neurotoxicity: No information found.
Other Studies:

Section 12 - Ecological Information


Ecotoxicity: No data available. No information available.
Environmental: Terrestrial: No information found in the available literature however, Epinephrine should be highly mobile in soils, and it may leach to ground water. However, it is unstable in the presence of light, heat, air and alkalies so it has the potential to undergo direct photolysis and various chemical reactions in the soil. Aquatic Fate: None located in the available literature however, expected to undergo changes similar to those expected in soil. Atmospheric Fate: Expected to exist almost entirely in the particulate phase in ambient air. It has an estimated half-life of about three hours.
Physical: No information available.
Other: No information available.

Section 13 - Disposal Considerations


Chemical waste generators must determine whether a discarded chemical is classified as a hazardous waste. US EPA guidelines for the classification determination are listed in 40 CFR Parts 261.3. Additionally, waste generators must consult state and local hazardous waste regulations to ensure complete and accurate classification.
RCRA P-Series: CAS# 51-43-4: waste number P042.
RCRA U-Series: None listed.

Section 14 - Transport Information


 

 

US DOT

Canada TDG

Shipping Name:

DOT regulated - small quantity provisions apply (see 49CFR173.4)

TOXIC SOLID ORGANIC NOS (EPINEPHRINE)

Hazard Class:

 

6.1

UN Number:

 

UN2811

Packing Group:

 

II

 

Section 15 - Regulatory Information


US FEDERAL

TSCA
     CAS# 51-43-4 is listed on the TSCA inventory.
Health & Safety Reporting List
     None of the chemicals are on the Health & Safety Reporting List.
Chemical Test Rules
     None of the chemicals in this product are under a Chemical Test Rule.
Section 12b
     None of the chemicals are listed under TSCA Section 12b.
TSCA Significant New Use Rule
     None of the chemicals in this material have a SNUR under TSCA.
CERCLA Hazardous Substances and corresponding RQs
     CAS# 51-43-4: 1000 lb final RQ; 454 kg final RQ
SARA Section 302 Extremely Hazardous Substances
     None of the chemicals in this product have a TPQ.
SARA Codes
     CAS # 51-43-4: acute, chronic.
Section 313      No chemicals are reportable under Section 313.
Clean Air Act:
     This material does not contain any hazardous air pollutants.
     This material does not contain any Class 1 Ozone depletors.
     This material does not contain any Class 2 Ozone depletors.
Clean Water Act:
     None of the chemicals in this product are listed as Hazardous Substances under the CWA.
     None of the chemicals in this product are listed as Priority Pollutants under the CWA.
     None of the chemicals in this product are listed as Toxic Pollutants under the CWA.
OSHA:
     None of the chemicals in this product are considered highly hazardous by OSHA.
STATE
     CAS# 51-43-4 can be found on the following state right to know lists: New Jersey, Pennsylvania, Massachusetts.

California Prop 65

California No Significant Risk Level: None of the chemicals in this product are listed.

European/International Regulations

European Labeling in Accordance with EC Directives
Hazard Symbols:
     T
Risk Phrases:

     R 23/24/25 Toxic by inhalation, in contact with skin and if
     swallowed.
     R 33 Danger of cumulative effects.
     R 36/37/38 Irritating to eyes, respiratory system and skin.

Safety Phrases:

     S 23 Do not inhale gas/fumes/vapour/spray.
     S 26 In case of contact with eyes, rinse immediately with plenty of
     water and seek medical advice.
     S 36/37/39 Wear suitable protective clothing, gloves and eye/face
     protection.
     S 45 In case of accident or if you feel unwell, seek medical advice
     immediately (show the label where possible).

WGK (Water Danger/Protection)

     CAS# 51-43-4: 3
Canada - DSL/NDSL
     CAS# 51-43-4 is listed on Canada's DSL List.
Canada - WHMIS
     This product has a WHMIS classification of D1A, D2B.
Canadian Ingredient Disclosure List

Section 16 - Additional Information


Prepared by: BLULUX LABORATORIES (P) LTD.

For questions contact:: Blulux Laboratories Pvt. Ltd.

79/66-B, I.H.I.Complex, Industrial Area, N.I.T. Faridabad, Haryana-121001

TEL: :++91-129-5021360, 2444433, 2237762  FAX:++ 91129-5027762 E-MAIL: blulux@rediffmail.com

The statements contained herein are offered for informational purposes only and are based upon technical data that Blulux Laboratories Pvt. Ltd.  believes to be accurate. It is intended for use only by persons having the necessary technical skills and at their own discretion and risk. Since conditions and manner of use are outside our control, we make NO WARRANTY, EXPRESS OR IMPLIED, OF MERCHANTABILITY, FITNESS OR OTHERWISE.

 

Mfgs. & Exporters: Laboratory Reagents, Fine Chemicals, Analytical Reagents & Dehydrated Culture Media